http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20020954-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cf7f3f36d20185ce15a2d1f04d5fdc1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
filingDate 2002-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33243f0b0c7e9499b1eee27a85dccacf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca89f481d4aabe02c67b4b0b4392384d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e9530e5c15f5e11b31e9960bf7a60de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52d5709c06bc98758b03d60b37766377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92e0bbaf4f592d3dee0338f3ce77d12f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efada5551b85967ffa1425cde281676c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0373f2787d380cab9d7def2ea616bad5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a79148a95ad1d4777b62be9e7274284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e283c7199820f1a861e3844cd08d6363
publicationDate 2002-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20020954-A1
titleOfInvention SUBSTITUTE DERIVATIVES OF PYRIMIDONE AS LIGANDS OF INTEGRIN RECEPTORS
abstract REFERS TO PYRIMIDONE SUBSTITUTE DERIVATIVES OF FORMULA B-G-L; WHERE L IS -U-C (T) (RL7) (RL8); T IS COOH; U ES - (CRL1RL2) a- (VL) b- (CRL3RL4) c- (WL) d- (CRL5RL6) e- (XL) f; a, c, e ARE 0-3; b, d, f ARE 0-1; RL1, RL2, RL3, RL4, RL5, RL6 ARE H, HALOGEN, HYDROXYL, C1-C6 ALKYL, - (CH2) w- (YL) y-RL9, AMONG OTHERS; w IS 0-4; and ES 0-1; YL IS CO, WITH (RY1), N (RY1) CO, AMONG OTHERS; RY1 IS H, C1-C6 ALKYL, C1-C6 ALCOXYALKYL, AMONG OTHERS; RL7, RL8 ARE H, HALOGEN, HYDROXYL, C1-C6 ALKYL, AMONG OTHERS; RL9 IS H, OH, CN, HALOGEN, AMONG OTHERS; WL IS A 4-11 MEMBER POLYCYCLIC HYDROCARBON; VL, XL ARE CO, CONRL10, NRL10CO, S, SO, AMONG OTHERS; RL10 IS H, C1-C6 ALKYL, C1-C6 ALCOXYALKYL, AMONG OTHERS; G IS AN IG GROUP; ZG ES O, S, NRG3; RG1, RG2 ARE H, CN, NO2, HALOGEN, C1-C6 ALKYL, AMONG OTHERS; RG3 IS H, OH, C1-C6 ALKYL, AMONG OTHERS. B IS AN ATOM THAT CAN FORM HYDROGEN BRIDGES. PREFERRED COMPOUNDS ARE TRIFLUOROACETATE OF 2 - [(1- {1- [2-CARBOXY-3- (2-NAPHTHYL) PROPYL] -5-METHYL-2-OXO-1,2-DIHYDROPYRIMIDIN-4-IL} -PIPERIDIN- 4-IL) AMINO] -1H-BENZYMIDAZOLE) -1IO; 2 - {[(1- {1 - [(2S) -2-CARBOXI-3-PHENYLPROPYL] -5-METHYL-2-OXO-1,2-DIHYDROPYRIMIDIN-4-IL} -PIPERIDIN-4-IL ACETATE ) METHYL] AMINO} -PYRIDINIUM, AMONG OTHERS. THE COMPOUNDS ARE LIGANDS OF THE Ovß3 INTEGRIN RECEPTOR AND MAY BE USEFUL FOR THE TREATMENT OF ATHEROSCLEROSIS, RHEUMATOID ARTHRITIS, RESTENOSIS, ANGIOPLASTY, ACUTE KIDNEY FAILURE, OSTEOPOROSIS, CANCER, TRICULAR CICATRIZATION OR HUMAN HEALING
priorityDate 2001-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2761212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416175303

Total number of triples: 74.